OM Outset Medical, Inc.

Outset Medical, Inc. is a rapidly growing medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. Its Tablo® Hemodialysis System (Tablo) represents a significant technological advancement enabling novel, transformational dialysis care in acute and home settings. Tablo was designed from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone.

$14.98  +0.26 (1.77%)
As of 09/26/2022 14:20:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  09/15/2020
Outstanding shares:  48,007,301
Average volume:  467,967
Market cap:   $722,029,807
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMGWSL0
Valuation   (See tab for details)
PE ratio:   -5.10
PB ratio:   2.04
PS ratio:   6.55
Return on equity:   -40.18%
Net income %:   -125.91%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy